No Data
No Data
SA Asks: How Will Changes at FDA Impact Vaccine Makers?
Emergent Biosolutions: Strategic Share Repurchase and Diversified Revenue Streams Signal Strong Buy Opportunity
Emergent BioSolutions Announces $50M Stock Repurchase Program
Express News | Emergent BioSolutions Inc - Authorizes $50 Million Stock Repurchase Program
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com